Nintedanib for Advanced Epithelial Ovarian Cancer: A Change of Perspective? Summary of Evidence from a Systematic Review
Conclusion: Despite the promising results, further studies are needed to evaluate Nintedanib efficacy in women affected by EOC.Gynecol Obstet Invest
Source: Gynecologic and Obstetric Investigation - Category: OBGYN Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Epithelial Cancer | OBGYN | Oral Cancer | Ovarian Cancer | Ovaries | Study | Women